Phio Pharmaceuticals announces annual shareholder meeting

• Phio Pharmaceuticals will hold its annual stockholder meeting virtually on Sept. 28, 2026.
• Shareholders will vote to elect six directors to serve until the 2027 annual meeting.
• Ballot includes ratification of Grant Thornton as independent auditor for the year ending Dec. 31, 2026.
• Investors will also consider amending the 2020 long-term incentive plan to add 1,500,000 shares for equity awards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-027997), on August 14, 2026, and is solely responsible for the information contained therein.